Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 16,96116,980 of 20,252 grants

Active NON-SBIR/STTR RPGS
Molecular Mechanisms of APOBEC-Induced Mutagenesis in Cancer
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2021 – 2026

PROJECT SUMMARY Tumor heterogeneity is the main cause of resistance to current chemotherapy drugs as well as metastasis development, leading to patients' death. Within the sam...

$967.6K
USD
Active NON-SBIR/STTR RPGS
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer
NATIONAL CANCER INSTITUTE Emory University United States 2021 – 2026

Project Summary Resistance to therapy is the major challenge for the treatment of pancreatic cancer. Despite recent successes in immune checkpoint therapy of several human cancer t...

$692.5K
USD
Completed NON-SBIR/STTR RPGS
Realizing the radiobiological impact of protons and high-LET particles in head and neck cancer and glioblastoma models
NATIONAL CANCER INSTITUTE University of Birmingham United Kingdom 2021 – 2026

Project Summary Radiotherapy is still one of the most effective cancer treatments used to treatment ~50 % of all human cancers, and particularly solid tumours of the head and neck...

$3.18M
USD
Active NON-SBIR/STTR RPGS
Molecular Mechanisms of APOBEC-Induced Mutagenesis in Cancer
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2021 – 2026

PROJECT SUMMARY Tumor heterogeneity is the main cause of resistance to current chemotherapy drugs as well as metastasis development, leading to patients' death. Within the sam...

$792.2K
USD
Active NON-SBIR/STTR RPGS
Persistent STAT5 signaling in polyfunctional CD4 T cells and its application in adoptive T cell therapy
NATIONAL CANCER INSTITUTE Augusta University United States 2021 – 2026

Project summary/abstract Recent advances in adoptive T-cell therapy (ACT), especially CD19-targeting chimeric antigen receptor (CAR) T-cell therapy (CD19CART), have highlighted the...

$4.97M
USD
Active NON-SBIR/STTR RPGS
AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2026

SUMMARY Liver cancer is the fourth leading cause of cancer related mortality worldwide. Currently, in addition to emerging immune checkpoint inhibitors, a small number of structura...

$5.99M
USD
Active NON-SBIR/STTR RPGS
Elucidating the role of DNAPKcs in chromosomal break end joining and clastogen resistance
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2021 – 2026

SUMMARY. Kinase inhibitors targeting the catalytic subunit of the DNA-dependent protein kinase (DNAPKcs) are being developed to sensitize tumors to clastogenic (chromosomal-breakin...

$918.4K
USD
Active NON-SBIR/STTR RPGS
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2021 – 2026

Chemotherapy-related cognitive impairment (CRCI, chemobrain), chemotherapy-induced peripheral neuropathy (CIPN) and gait changes are debilitating side-effects of cancer treatment w...

$825.1K
USD
Active NON-SBIR/STTR RPGS
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2021 – 2026

Chemotherapy-related cognitive impairment (CRCI, chemobrain), chemotherapy-induced peripheral neuropathy (CIPN) and gait changes are debilitating side-effects of cancer treatment w...

$954.7K
USD
Active NON-SBIR/STTR RPGS
Improving the translational value of head and neck cancer patient-in-mouse models
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2026

Project Summary Patient-derived model systems are commonly used to study tumor biology and test novel treatments for head and neck cancer. Our goal is to improve the use of mammali...

$848.9K
USD
Active NON-SBIR/STTR RPGS
Diagnosis of Cancer in the Emergency Room - Explaining Persistent Disparities - Diversity Supplement
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2026

Abstract Cancer is a common diagnosis in the emergency department (ED) and by the time patients reach the ED, their cancer hasoften progressed to later stages. Lung cancer is the d...

$1.2M
USD
Active NON-SBIR/STTR RPGS
Targeting TET DNA Dioxygenases as Therapeutic Principle in Myeloid Neoplasms
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Ten Eleven Translocation (TET1, TET2 and TET3) are α-ketoglutarate (αKG) and Fe2+ dependent DNA- dioxygenases that is a key regulator of epigenetic landsca...

$5.78M
USD
Completed NON-SBIR/STTR RPGS
Investigating Cellular Communication in the Tumor Microenvironment in Pancreatic Cancer
NATIONAL CANCER INSTITUTE Henry Ford Health System United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Pancreatic ductal adenocarcinoma (PDA) is projected to become the 2nd leading cause of cancer-related deaths world-wide by 2030, largely due a lack of effe...

$3.5M
USD
Active NON-SBIR/STTR RPGS
In Vivo Testing of Novel Drug Combinations for Pediatric Soft Tissue Sarcomas
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2021 – 2026

PROJECT SUMMARY Despite the advances made in our understanding of the etiology of pediatric soft tissue sarcomas (STS), the overall survival of those diseases has not significantly...

$7.67M
USD
Completed NON-SBIR/STTR RPGS
Adapting and Testing a Novel Self-Compassion Intervention to Reduce Lung Cancer Stigma
NATIONAL CANCER INSTITUTE Loyola Marymount University United States 2021 – 2025

Project Summary Given advances in screening and treatment, the number of people in the U.S. living with lung cancer is expected to increase by 25% (from 571,340 to 724,610) by 2030...

$2.49M
USD
Active NON-SBIR/STTR RPGS
Improving the Timeliness and Quality of Care for Rural Lung and Head-and-Neck Cancer Patients
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2021 – 2027

ABSTRACT: Improving the timeliness and quality of care for lung cancer (LC) and head and neck cancer (HNC) patients is of utmost importance because delays in treatment initiation a...

$4.98M
USD
Completed NON-SBIR/STTR RPGS
Dissecting the oncogenic and pro-metastatic roles of PTHLH-mediated calcium signaling in pancreatic cancer
NATIONAL CANCER INSTITUTE University of Massachusetts Med Sch Worc... United States 2021 – 2025

PROJECT SUMMARY Pancreatic cancer is a major health issue in the US, with only 7% of patients surviving beyond 5-years and nearly all patients presenting with metastases. Identifyi...

$2.49M
USD
Active NON-SBIR/STTR RPGS
The role of the macroenvironment in pancreatic cancer-induced cachexia
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2026

PROJECT SUMMARY: OVERALL The overall goal of this Program Project is to gain a better understanding of the underlying mechanisms that drive cachexia in cancer patients, especially...

$19.67M
USD
Active NON-SBIR/STTR RPGS
Project 1 – IL-6/STAT3/NF-kB in Adipose-Muscle Crosstalk in the Pancreatic Cancer Macroenvironment
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2026

PROJECT SUMMARY: PROJECT 1 Cancer cachexia, or progressive weight loss featuring immunodysmetabolism, causes ~1/3 of cancer deaths. Loss of muscle mass reduces performance status,...

Active NON-SBIR/STTR RPGS
Project 2 NF-#B regulation in muscle wasting and pancreatic cancer-induced cachexia
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2026

PROJECT SUMMARY: PROJECT 2 Cachexia is a debilitating syndrome that results in severe, involuntary weight loss due to the depletion of skeletal muscle and adipose tissues. This syn...